Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia.

Iyer VN, Brinjikji W, Apala D, Pannu BS, Kotecha A, Leise MD, Kamath PS, Misra S, Lanzino G, Krowka MJ, Wood CP, Swanson KL.

Adv Hematol. 2018 Feb 11;2018:4798425. doi: 10.1155/2018/4798425. eCollection 2018.

2.

Assessment of the spectrum of hepatic encephalopathy: A multicenter study.

Reuter B, Walter K, Bissonnette J, Leise MD, Lai J, Tandon P, Kamath PS, Biggins SW, Rose CF, Wade JB, Bajaj JS.

Liver Transpl. 2018 May;24(5):587-594. doi: 10.1002/lt.25032.

PMID:
29457869
3.

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding.

Iyer VN, Apala DR, Pannu BS, Kotecha A, Brinjikji W, Leise MD, Kamath PS, Misra S, Begna KH, Cartin-Ceba R, DuBrock HM, Krowka MJ, O'Brien EK, Pruthi RK, Schroeder DR, Swanson KL.

Mayo Clin Proc. 2018 Feb;93(2):155-166. doi: 10.1016/j.mayocp.2017.11.013. Epub 2018 Jan 24. Erratum in: Mayo Clin Proc. 2018 Mar;93(3):396.

PMID:
29395350
4.

Systematic review of mixed cryoglobulinemia associated with hepatitis E virus infection: association or causation?

Bazerbachi F, Leise MD, Watt KD, Murad MH, Prokop LJ, Haffar S.

Gastroenterol Rep (Oxf). 2017 Aug;5(3):178-184. doi: 10.1093/gastro/gox021. Epub 2017 May 19. Review.

5.

Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence".

Yang JD, Leise MD.

J Hepatol. 2017 Dec;67(6):1357. doi: 10.1016/j.jhep.2017.08.001. Epub 2017 Aug 9. No abstract available.

PMID:
28800877
6.

Reply.

Yang JD, Leise MD.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1814. doi: 10.1016/j.cgh.2017.07.034. Epub 2017 Aug 4. No abstract available.

PMID:
28782669
7.

Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works.

Segraves JM, Cartin-Ceba R, Leise MD, Krowka MJ.

Hepatol Res. 2018 Feb;48(3):E340-E346. doi: 10.1111/hepr.12930. Epub 2017 Aug 31.

PMID:
28667665
8.

Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors.

Han S, Yang JD, Sinn DH, Kim JM, Choi GS, Jung G, Ahn JH, Kim S, Ko JS, Gwak MS, Kwon CHD, Leise MD, Gwak GY, Heimbach JK, Kim GS.

Ann Surg. 2017 Jun 16. doi: 10.1097/SLA.0000000000002318. [Epub ahead of print]

PMID:
28628564
9.
10.

Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis.

Ahmed Mohammed HA, Yang JD, Giama NH, Choi J, Ali HM, Mara KC, Harmsen WS, Wiesner RH, Leise MD, Therneau TM, Roberts LR.

Liver Cancer. 2017 Feb;6(2):126-136. doi: 10.1159/000450833. Epub 2016 Dec 17.

11.

Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multicenter IDOL Consortium.

Goldberg DS, Karp SJ, McCauley ME, Markmann JF, Croome KP, Taner CB, Heimbach JK, Leise MD, Fryer JP, Bohorquez HE, Cohen AJ, Gilroy RK, Kumer SC, Foley DP, Karim AS, Hernandez-Alejandro R, Levstik MA, Abt PL.

Transplantation. 2017 May;101(5):1067-1073. doi: 10.1097/TP.0000000000001656.

PMID:
28114173
12.

Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.

Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ, Roberts LR, Heimbach JA, Leise MD.

Clin Gastroenterol Hepatol. 2017 May;15(5):767-775.e3. doi: 10.1016/j.cgh.2016.11.034. Epub 2016 Dec 21.

13.

Reply.

Lynn AM, Leise MD.

Liver Transpl. 2016 Dec;22(12):1736-1737. doi: 10.1002/lt.24647. No abstract available.

14.

Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma.

Yang JD, Aqel BA, Pungpapong S, Gores GJ, Roberts LR, Leise MD.

J Hepatol. 2016 Oct;65(4):859-860. doi: 10.1016/j.jhep.2016.06.023. Epub 2016 Jul 5. No abstract available.

PMID:
27392425
15.

Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.

Lynn AM, Singh S, Congly SE, Khemani D, Johnson DH, Wiesner RH, Kamath PS, Andrews JC, Leise MD.

Liver Transpl. 2016 Jun;22(6):723-31. doi: 10.1002/lt.24440.

16.

Evaluation of liver stiffness with magnetic resonance elastography in patients with constrictive pericarditis: Preliminary findings.

Fenstad ER, Dzyubak B, Oh JK, Williamson EE, F Glockner J, Young PM, Anavekar NS, Leise MD, Ehman RL, Araoz PA, Venkatesh SK.

J Magn Reson Imaging. 2016 Jul;44(1):81-8. doi: 10.1002/jmri.25126. Epub 2015 Dec 21.

17.

The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.

Doycheva I, Leise MD, Watt KD.

Transplantation. 2016 Jan;100(1):61-8. doi: 10.1097/TP.0000000000001008. Review.

PMID:
26647107
18.

Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk.

Fussner LA, Heimbach JK, Fan C, Dierkhising R, Coss E, Leise MD, Watt KD.

Liver Transpl. 2015 Jul;21(7):889-96. doi: 10.1002/lt.24137.

19.

64-year-old woman with diarrhea and increased abdominal girth.

Shih HH, Law RJ, Leise MD.

Mayo Clin Proc. 2015 Apr;90(4):e35-9. doi: 10.1016/j.mayocp.2014.07.023. No abstract available.

PMID:
25841264
20.

Endoscopic ultrasound-guided portal-systemic pressure gradient measurement.

Fujii-Lau LL, Leise MD, Kamath PS, Gleeson FC, Levy MJ.

Endoscopy. 2014;46 Suppl 1 UCTN:E654-6. doi: 10.1055/s-0034-1390845. Epub 2014 Dec 19. No abstract available.

PMID:
25526410

Supplemental Content

Loading ...
Support Center